DLF IPO fully subscribed (The Hindu)
MUMBAI: The mega initial public offer of realty giant DLF, through which the developer is expecting to garner Rs 9,625 crore, on Tuesday got fully subscribed.

Strides Arcolab gets NDA approvals from US-FDA for HIV/AIDS drugs (PharmaBiz)
Strides Arcolab has received tentative approvals from the United States - Food and Drug Administration for two new drug applications (NDA) for fixed dose combination of lamivudine/stavudine 150 mg/40 mg tablets co-packaged with efavirenz 600mg tablets and lamivudine/zidovudine 150/300 mg tablets co-packaged with efavirenz 600mg tablets both under the expedited review provisions of the President's ...